J Korean Med Assoc.  2017 Feb;60(2):118-125. 10.5124/jkma.2017.60.2.118.

Recent updates on treatment for pediatric migraine

• Lee KH

• KMID: 2368921
• DOI: http://doi.org/10.5124/jkma.2017.60.2.118

Abstract

Pediatric migraine is a disorder that significantly interferes with the everyday life and school life of approximately 8% of children and adolescents in Korea. Recently, studies on migraine have been carried out very rapidly, many drugs have been developed, and acute-phase and preventive treatments for migraine have been evaluated. Therefore, it is necessary to understand the diagnostic criteria and degree of impairment in pediatric migraine and to become familiar with up-to-date treatment methods in children. Research into the use of botulinum toxin or calcitonin gene-related peptide antagonists to treat adult migraine headaches is progressing, and we expect these therapies to be applicable to pediatric patients soon. Many students in our country are suffering from migraines in their daily life. Therefore, we need to acquire the relevant knowledge and identify practical treatment methods for pediatric migraine in children and adolescents in order to reduce their pain.

Keyword

Pediatric migraine; Child; Adolescent; Therapeutics

MeSH Terms

Adolescent
Adult
Botulinum Toxins
Calcitonin Gene-Related Peptide
Child
Humans
Korea
Migraine Disorders*
Botulinum Toxins
Calcitonin Gene-Related Peptide